You have 9 free searches left this month | for more free features.

Moderately active

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transfemoral Amputation Trial in Wiesbaden (Amputation-specialized rehabilitation, Non-amputation-specialized rehabilitation)

Recruiting
  • Transfemoral Amputation
  • Amputation-specialized rehabilitation
  • Non-amputation-specialized rehabilitation
  • Wiesbaden, Germany
    MEDIAN Clinics
Sep 13, 2023

Oxidative Stress, Inflammation Trial in Corciano (Ozonized vegetable oil with vitamines)

Active, not recruiting
  • Oxidative Stress
  • Inflammation
  • Ozonized vegetable oil with vitamines
  • Corciano, Perugia, Italy
    Crabion srl
Oct 20, 2022

Muscle Soreness, Pain, Muscle Damage Trial in Cork (Turmipure Gold®, Placebo)

Completed
  • Muscle Soreness
  • +2 more
  • Turmipure Gold®
  • Placebo
  • Cork, Ireland
    Atlantia Food Clinical Trials
Dec 9, 2022

Colitis, Ulcerative Trial (JNJ-77242113, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • (no location specified)
Sep 15, 2023

Pain, Acute, Pain, Chronic, Knee Osteoarthritis Trial in La Ñora (COLLAGEN (COL), PLACEBO (PLA))

Recruiting
  • Pain, Acute
  • +3 more
  • COLLAGEN (COL)
  • PLACEBO (PLA)
  • La Ñora, Murcia, Spain
    Research Center for High Performance Sport. Catholic University
Jun 14, 2023

Ulcerative Colitis Trial (Tilpisertib Fosmecarbil, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Tilpisertib Fosmecarbil
  • Placebo
  • (no location specified)
Sep 1, 2023

Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

Not yet recruiting
  • Crohn's Disease
  • Risankizumab SC
  • Placebo for risankizumab
  • (no location specified)
Sep 26, 2023

Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

Completed
  • Rheumatoid Arthritis
  • LNK01001 Dose A
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Ulcerative Colitis, Ulcerative Colitis Chronic Trial (Mirikizumab)

Not yet recruiting
  • Ulcerative Colitis
  • Ulcerative Colitis Chronic
  • (no location specified)
Mar 6, 2023

Ulcerative Colitis Trial (Mirikizumab IV, Mirikizumab SC)

Not yet recruiting
  • Ulcerative Colitis
  • Mirikizumab IV
  • Mirikizumab SC
  • (no location specified)
Mar 24, 2023

Crohn Disease Trial in Tyler (VTX958, VTX958 Placebo)

Recruiting
  • Crohn Disease
  • Tyler, Texas
    Local Site # 840101
Jan 17, 2023

Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)

Not yet recruiting
  • Ulcerative Colitis
  • IV MK-7240
  • +3 more
  • (no location specified)
Sep 27, 2023

Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Whittier, California
    New Hope Research Development
Feb 15, 2023

Ulcerative Colitis Trial (Efavaleukin alfa, Placebo)

Not yet recruiting
  • Ulcerative Colitis
  • Efavaleukin alfa
  • Placebo
  • (no location specified)
Jan 3, 2023

Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)

Active, not recruiting
  • Crohn's Disease
  • CT-P13 SC (Infliximab)
  • Placebo SC
  • Warszawa, Poland
    WIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022

Crohn's Disease Trial (Risankizumab)

Not yet recruiting
  • Crohn's Disease
  • (no location specified)
Aug 10, 2023

Ulcerative Colitis Trial in United States (ALTB-268)

Recruiting
  • Ulcerative Colitis
  • ALTB-268
  • Wellington, Florida
  • +6 more
Nov 6, 2023

Colitis Ulcerative Trial in Miami Lakes, Charlotte (Dupilumab, Placebo)

Recruiting
  • Colitis Ulcerative
  • Miami Lakes, Florida
  • +1 more
Feb 15, 2023

Disease Activity and Adverse Events in Adolescent and Adult

Recruiting
  • Crohn's Disease
    • Toyota-shi, Aichi, Japan
    • +1 more
    Aug 29, 2023

    Safety of Filgotinib in Ulcerative Colitis (UC)

    Not yet recruiting
    • Ulcerative Colitis
    • Pierre-Bénite, France
      Centre Hospitalier Lyon Sud
    Apr 18, 2023

    IBD, Colitis, Ulcerative Trial in Australia, United States (MORF-057, Placebo)

    Recruiting
    • Inflammatory Bowel Diseases
    • Colitis, Ulcerative
    • Sun City, Arizona
    • +13 more
    Jan 24, 2023

    Ulcerative Colitis Trial in Worldwide (BT051 200 mg, BT051 800 mg, BT051 3200 mg)

    Completed
    • Ulcerative Colitis
    • BT051 200 mg
    • +3 more
    • Rialto, California
    • +5 more
    Dec 13, 2022

    Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

    Not yet recruiting
    • Ulcerative Colitis
    • Crohn's Disease
    • Vedolizumab IV
    • Vedolizumab SC
    • (no location specified)
    Oct 17, 2023

    Ulcerative Colitis Trial (Intravenous (IV) infusions)

    Not yet recruiting
    • Ulcerative Colitis
    • Intravenous (IV) infusions
    • (no location specified)
    Mar 14, 2023

    Crohn Disease Trial in Cleveland, Miskolc, Madrid (Ozanimod)

    Not yet recruiting
    • Crohn Disease
    • Cleveland, Ohio
    • +2 more
    Jul 21, 2022